Methods, agents, and devices for local neuromodulation of autonomic nerves
Methods, agents, and devices to treat medical conditions through local chemical neuromodulation of the autonomic nervous system are described. Drug formulations may be injected at or near ganglia, nerve plexi, ganglionated plexi, and nerves to treat different diseases. Target sites for the treatment of cardiac and other disease conditions may include extrinsic stellate (cervicothoracic) and cervical ganglia of the sympathetic chain, and intrinsic cardiac nerves and ganglionated plexi innervating the myocardium.
1. A method for treating angina in a patient, the method comprising:
delivering a composition comprising amiodarone locally to a stellate ganglion of the patient in an amount sufficient to affect function of the stellate ganglion and alleviate one or more symptoms of angina in the patient.
2. The method of claim 1 , comprising delivering the agent in a composition comprising a PEG carrier.
3. The method of claim 1 , comprising delivering the agent in a composition comprising a contrast agent.
4. The method of claim 1 , comprising delivering the agent in a composition comprising a hydrogel.
5. The method of claim 1 , comprising delivering the agent in a composition comprising a biostable polymer.
6. The method of claim 1 , comprising delivering the agent in a composition comprising a biodegradable polymer.
7. A method for treating angina in a patient, the method comprising:
delivering a composition comprising amiodarone locally to a stellate ganglion of the patient in an amount sufficient to affect function of the stellate ganglion and alleviate one or more symptoms of angina in the patient; and
measuring electrical signals directly transmitted from the stellate ganglion.
8. The method of claim 7 , wherein the stellate ganglion is accessed via an anterior paratracheal approach.
9. The method of claim 7 , comprising measuring the electrical signals transmitted from the stellate ganglion before and after delivering the agent to the stellate ganglion.
10. The method of claim 7 , wherein the stellate ganglion is accessed via a supraclavicular approach.
11. The method of claim 7 , wherein the stellate ganglion is accessed via an endovascular approach.
12. The method of claim 7 , wherein the composition further comprises a hydrogel.
13. The method of claim 12 , wherein the hydrogel comprises PEG.
14. A method for treating angina in a patient, the method comprising:
delivering a composition comprising a dihydropyridine calcium antagonist locally to a stellate ganglion of the patient in an amount sufficient to affect function of the stellate ganglion and alleviate one or more symptoms of angina in the patient.
15. The method of claim 14 , wherein the dihydropyridine calcium antagonist comprises amlodipine.
16. The method of claim 14 , wherein the dihydropyridine calcium antagonist comprises nifedipine.